Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
ReShape Rx, LLC
Not verified in the bound record.
Not verified in the bound record.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
verified first party
Section 503B
not found in current fda registry check
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA warning-letter/Form 483/current-503B and Texas board sources were checked. No matching action was found in the bounded sources; this is not a claim that none exists.
No regulatory action was found in the bounded search. That is not a categorical absence claim.
No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Licensed 503A Sterile Compounding. ReShape Rx New Braunfels 109 S IH-35, Suite B New Braunfels, TX 78130
As a fully licensed sterile and non-sterile compounding pharmacy - ReShape adheres to all USP<797> and regulatory guidelines
RESHAPE RX, LLC, NPI: 1063255131, 109 INTERSTATE 35 S NEW BRAUNFELS, TX 78130-4817
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 0 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.